Filing Details

Accession Number:
0000919574-18-008212
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-28 17:39:27
Reporting Period:
2018-12-26
Accepted Time:
2018-12-28 17:39:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1634432 Strongbridge Biopharma Plc SBBP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325713 Bruce Kovner C/O Caxton Corporation
731 Alexander Road, Bldg. 2
Princeton NJ 08540
No No Yes No
1388551 Caxton Corp 731 Alexander Road
Building 2
Princeton NJ 08540
No No Yes No
1576081 Cdk Associates, L.l.c. C/O Caxton Corporation
731 Alexander Road, Bldg. 2
Princeton NJ 08540
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, $0.01 Par Value Acquisiton 2018-12-26 31,197 $4.00 6,563,105 No 4 P Direct
Ordinary Shares, $0.01 Par Value Acquisiton 2018-12-27 18,200 $3.98 6,581,305 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Following the transactions reported herein, these shares represent (a) 6,244,501 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 336,804 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation.